61
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE Cellular and Molecular Biology

Mechanism of Growth Inhibitory Effects of Cyclooxygenase-2 Inhibitor–NS398 on Cancer Cells

, , , , &
Pages 333-337 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

La-ongsri Atchaneeyasakul, Mongkol Uiprasertkul & Adisak Trinavarat. (2010) Cyclooxygenase-2 Expression in Retinoblastoma: An Immunohistochemical Analysis. Current Eye Research 35:3, pages 242-247.
Read now

Articles from other publishers (12)

Qian Li, Jie Peng, Ting Liu & Guiying Zhang. (2017) Effects of celecoxib on cell apoptosis and Fas, FasL and Bcl-2 expression in a BGC-823 human gastric cancer cell line. Experimental and Therapeutic Medicine 14:3, pages 1935-1940.
Crossref
Antonio Taddei, Valentina Fabbroni, Alessandro Pini, Laura Lucarini, Maria Novella Ringressi, Ornella Fantappi?Daniele Bani, Luca Messerini, Emanuela Masini & Paolo Bechi. (2013) Cyclooxygenase-2 and Inflammation Mediators Have a Crucial Role in Reflux-Related Esophageal Histological Changes and Barrett?s Esophagus. Digestive Diseases and Sciences 59:5, pages 949-957.
Crossref
Aline Corrêa Abrahão, Fernanda Salgueiredo Giudice, Felipe Fornias Sperandio & Décio dos Santos Pinto Junior. (2013) Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine 42:10, pages 793-798.
Crossref
Yu-Jie Wang, Xiao-Ping Niu, Li Yang, Zhen Han & Ying-Jie Ma. (2013) Effects of Celecoxib on Cycle Kinetics of Gastric Cancer Cells and Protein Expression of Cytochrome C and Caspase-9. Asian Pacific Journal of Cancer Prevention 14:4, pages 2343-2347.
Crossref
Il Han Song, Suk Bae Kim, Hyun Duk Shin, Ha Yan Kang & Eun Young Kim. (2012) NS-398 induces caspase-dependent, mitochondria-mediated intrinsic apoptosis of hepatoma cells. Advances in Bioscience and Biotechnology 03:06, pages 649-656.
Crossref
Hiam Naiditch, Michael R. Shurin & Galina V. Shurin. (2011) Targeting myeloid regulatory cells in cancer by chemotherapeutic agents. Immunologic Research 50:2-3, pages 276-285.
Crossref
S.-M. Che, X.-Z. Zhang, X.-L. Liu, X. Chen & L. Hou. (2011) The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells. Diseases of the Esophagus 24:4, pages 265-273.
Crossref
Z Shen, D Ye, X Zhang, Z Jiang, B Xiao & J Guo. (2010) Inhibitory effect of HuR gene small interfering RNA segment on laryngeal carcinoma Hep-2 cell growth . The Journal of Laryngology & Otology 124:11, pages 1183-1189.
Crossref
Sara L. O?Kane, Gina L. Eagle, John Greenman, Michael J. Lind & Lynn Cawkwell. (2010) COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines. Lung Cancer 67:2, pages 160-165.
Crossref
Tien-Shun Yeh, Chew-Wun Wu, Kai-Wen Hsu, Wan-Jung Liao, Min-Chieh Yang, Anna Fen-Yau Li, An-Ming Wang, Min-Liang Kuo & Chin-Wen Chi. (2009) The Activated Notch1 Signal Pathway Is Associated with Gastric Cancer Progression through Cyclooxygenase-2. Cancer Research 69:12, pages 5039-5048.
Crossref
A-Ram Park, Hyung-Seok KimChang-Soo Park. (2009) COX-2 and Survivin Expression in Neuroblastomas Associated with Tumor Growth and Behavior. Chonnam Medical Journal 45:1, pages 9.
Crossref
Jeong Won Jang. (2008) Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor. The Korean Journal of Hepatology 14:3, pages 305.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.